KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $12.20 $17.80 Friday, 26th Apr 2024 ENTA stock ended at $12.37. This is 0.88% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 3.66% from a day low at $12.20 to a day high of $12.65.
90 days $11.01 $17.80
52 weeks $8.08 $37.75

Historical Enanta Pharmaceuticals prices

Date Open High Low Close Volume
Mar 07, 2016 $29.48 $31.55 $28.90 $30.61 398 200
Mar 04, 2016 $29.49 $30.17 $29.21 $29.61 271 600
Mar 03, 2016 $30.09 $30.49 $28.77 $29.49 279 700
Mar 02, 2016 $29.65 $30.58 $29.64 $30.10 518 300
Mar 01, 2016 $28.51 $29.92 $28.27 $29.88 303 700
Feb 29, 2016 $28.16 $28.71 $27.67 $28.39 224 200
Feb 26, 2016 $28.64 $29.58 $27.73 $28.40 230 100
Feb 25, 2016 $28.50 $28.52 $27.67 $28.26 142 200
Feb 24, 2016 $27.81 $28.66 $26.50 $28.29 159 200
Feb 23, 2016 $29.28 $29.61 $28.08 $28.09 167 500
Feb 22, 2016 $29.45 $29.62 $28.63 $29.40 184 000
Feb 19, 2016 $27.62 $28.89 $26.71 $28.67 157 800
Feb 18, 2016 $29.21 $29.57 $27.72 $27.82 272 900
Feb 17, 2016 $29.00 $31.15 $28.20 $29.23 446 100
Feb 16, 2016 $26.99 $29.29 $26.82 $28.87 298 100
Feb 12, 2016 $25.82 $27.19 $24.34 $26.70 333 700
Feb 11, 2016 $23.80 $25.97 $23.03 $25.58 227 800
Feb 10, 2016 $23.51 $25.57 $23.48 $24.33 545 600
Feb 09, 2016 $26.66 $26.66 $22.68 $23.16 792 900
Feb 08, 2016 $22.37 $22.70 $20.39 $21.52 307 300
Feb 05, 2016 $23.86 $24.01 $22.55 $22.74 248 700
Feb 04, 2016 $23.38 $24.67 $23.25 $23.95 145 100
Feb 03, 2016 $23.41 $23.98 $22.02 $23.24 209 500
Feb 02, 2016 $23.29 $23.93 $22.63 $23.36 276 700
Feb 01, 2016 $25.59 $26.43 $23.35 $23.54 411 900
Click to get the best stock tips daily for free!

About Enanta Pharmaceuticals

Enanta Pharmaceuticals Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A pro... ENTA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT